Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Agranulocytosis | x | ||
| Ataxia | x | ||
| Confusional state | x | ||
| Constipation | x | ||
| Libido decreased | x | ||
| Drowsiness | x | ||
| Oedema | x | ||
| Blood disorder | x | ||
| Jaundice | x | ||
| Nausea | x | ||
| Syncope | x | ||
| Hepatic function abnormal | x | ||
| Menstruation irregular | x | ||
| Extrapyramidal symptoms | x | ||
| Eruption | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |